Joseph Kerrey

The Minerva Institute for Research & Scholarship engages in facilitating the administration of grant-funded research, and advocating for broad reform in higher education. The company is headquartered in San Francisco, CA.

The Minerva Institute for Research & Scholarship engages in facilitating the administration of grant-funded research, and advocating for broad reform in higher education. The company is headquartered in San Francisco, CA.

Circinus LLC provides administrative management and technical consulting services. It operates through the following divisions: Intelligence, Special Operations, Special Activities, and Law Enforcement. The firm offers operational intelligence support and training, force protection and operational training, partner engagement, organizational and technology assessment, cyber security and digital threat mitigation, and law enforcement and correctional facility operations. The company was founded by Alan Blaine Stone and Carson Edmondson on July 20, 2001 and is headquartered in Fredericksburg, VA.

The Minerva Institute for Research & Scholarship engages in facilitating the administration of grant-funded research, and advocating for broad reform in higher education. The company is headquartered in San Francisco, CA.

The Minerva Institute for Research & Scholarship engages in facilitating the administration of grant-funded research, and advocating for broad reform in higher education. The company is headquartered in San Francisco, CA.

The Minerva Institute for Research & Scholarship engages in facilitating the administration of grant-funded research, and advocating for broad reform in higher education. The company is headquartered in San Francisco, CA.

Allen & Co., Inc. engages in private placement, underwriting and brokerage services to entertainment and media companies. The company is headquartered in New York, NY.

Circinus LLC provides administrative management and technical consulting services. It operates through the following divisions: Intelligence, Special Operations, Special Activities, and Law Enforcement. The firm offers operational intelligence support and training, force protection and operational training, partner engagement, organizational and technology assessment, cyber security and digital threat mitigation, and law enforcement and correctional facility operations. The company was founded by Alan Blaine Stone and Carson Edmondson on July 20, 2001 and is headquartered in Fredericksburg, VA.

Circinus LLC provides administrative management and technical consulting services. It operates through the following divisions: Intelligence, Special Operations, Special Activities, and Law Enforcement. The firm offers operational intelligence support and training, force protection and operational training, partner engagement, organizational and technology assessment, cyber security and digital threat mitigation, and law enforcement and correctional facility operations. The company was founded by Alan Blaine Stone and Carson Edmondson on July 20, 2001 and is headquartered in Fredericksburg, VA.

Circinus LLC provides administrative management and technical consulting services. It operates through the following divisions: Intelligence, Special Operations, Special Activities, and Law Enforcement. The firm offers operational intelligence support and training, force protection and operational training, partner engagement, organizational and technology assessment, cyber security and digital threat mitigation, and law enforcement and correctional facility operations. The company was founded by Alan Blaine Stone and Carson Edmondson on July 20, 2001 and is headquartered in Fredericksburg, VA.

Circinus LLC provides administrative management and technical consulting services. It operates through the following divisions: Intelligence, Special Operations, Special Activities, and Law Enforcement. The firm offers operational intelligence support and training, force protection and operational training, partner engagement, organizational and technology assessment, cyber security and digital threat mitigation, and law enforcement and correctional facility operations. The company was founded by Alan Blaine Stone and Carson Edmondson on July 20, 2001 and is headquartered in Fredericksburg, VA.

Allen & Co., Inc. engages in private placement, underwriting and brokerage services to entertainment and media companies. The company is headquartered in New York, NY.

The Minerva Institute for Research & Scholarship engages in facilitating the administration of grant-funded research, and advocating for broad reform in higher education. The company is headquartered in San Francisco, CA.

Circinus LLC provides administrative management and technical consulting services. It operates through the following divisions: Intelligence, Special Operations, Special Activities, and Law Enforcement. The firm offers operational intelligence support and training, force protection and operational training, partner engagement, organizational and technology assessment, cyber security and digital threat mitigation, and law enforcement and correctional facility operations. The company was founded by Alan Blaine Stone and Carson Edmondson on July 20, 2001 and is headquartered in Fredericksburg, VA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

The Minerva Institute for Research & Scholarship engages in facilitating the administration of grant-funded research, and advocating for broad reform in higher education. The company is headquartered in San Francisco, CA.

The Minerva Institute for Research & Scholarship engages in facilitating the administration of grant-funded research, and advocating for broad reform in higher education. The company is headquartered in San Francisco, CA.

Circinus LLC provides administrative management and technical consulting services. It operates through the following divisions: Intelligence, Special Operations, Special Activities, and Law Enforcement. The firm offers operational intelligence support and training, force protection and operational training, partner engagement, organizational and technology assessment, cyber security and digital threat mitigation, and law enforcement and correctional facility operations. The company was founded by Alan Blaine Stone and Carson Edmondson on July 20, 2001 and is headquartered in Fredericksburg, VA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

The Minerva Institute for Research & Scholarship engages in facilitating the administration of grant-funded research, and advocating for broad reform in higher education. The company is headquartered in San Francisco, CA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

The Minerva Institute for Research & Scholarship engages in facilitating the administration of grant-funded research, and advocating for broad reform in higher education. The company is headquartered in San Francisco, CA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.

Circinus LLC provides administrative management and technical consulting services. It operates through the following divisions: Intelligence, Special Operations, Special Activities, and Law Enforcement. The firm offers operational intelligence support and training, force protection and operational training, partner engagement, organizational and technology assessment, cyber security and digital threat mitigation, and law enforcement and correctional facility operations. The company was founded by Alan Blaine Stone and Carson Edmondson on July 20, 2001 and is headquartered in Fredericksburg, VA.

Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.